Myriad Genetics, Inc. (MYGN)
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Financials
Quarterly
Annual
| INCOME STATEMENT | 02/2009 | 11/2008 | 08/2008 | 05/2008 |
|---|---|---|---|---|
| Sales | 8.71 Mil. | 7.53 Mil. | 9.05 Mil. | 5.98 Mil. |
| Gross Operating Profit | 75.66 Mil. | 66.12 Mil. | 157.81 Mil. | 55.79 Mil. |
| Operating Income before D & A (EBITDA) | 20.11 Mil. | 15.57 Mil. | 66.22 Mil. | -5.53 Mil. |
| Total Income Before Interest Expenses (EBIT) | 21.2 Mil. | 14.74 Mil. | 66.15 Mil. | -4.63 Mil. |
| Total Net Income | 21.2 Mil. | 14.45 Mil. | 65.54 Mil. | -4.63 Mil. |
| Basic EPS, Total | .46 | .32 | 1.47 | -0.1 |
| Diluted EPS, Total | .43 | .30 | 1.40 | -0.1 |
| BALANCE STATEMENT | 02/2009 | 11/2008 | 08/2008 | 05/2008 |
|---|---|---|---|---|
| Cash and Equivalents | 178.99 Mil. | 230.23 Mil. | 420.06 Mil. | 142.39 Mil. |
| Total Assets | 376.92 Mil. | 365.55 Mil. | NA | 252.95 Mil. |
| Total Liabilities | 53.82 Mil. | 54.18 Mil. | NA | 37.66 Mil. |
| Total Capitalization | 519.75 Mil. | 477.04 Mil. | 425.66 Mil. | 353.3 Mil. |
| CASH FLOW | 02/2009 | 11/2008 | 08/2008 | 05/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | 37.24 Mil. | -4.4 Mil. | NA | -8.1 Mil. |
| Net Cash From Investing Activities | -142.53 Mil. | -41.37 Mil. | NA | -11.32 Mil. |
| Net Cash From Financing Activities | 46.53 Mil. | 38.26 Mil. | NA | 18.39 Mil. |
| Net Change in Cash & Cash Equivalents | -58.75 Mil. | -7.5 Mil. | NA | -1.04 Mil. |
| INCOME STATEMENT | 08/2008 | 08/2007 | 08/2006 | 09/2005 |
|---|---|---|---|---|
| Sales | 32.34 Mil. | 23.27 Mil. | 20.79 Mil. | 14.23 Mil. |
| Gross Operating Profit | 301.29 Mil. | 133.86 Mil. | 93.49 Mil. | 68.18 Mil. |
| Operating Income before D & A (EBITDA) | 38.08 Mil. | -40.18 Mil. | -38.73 Mil. | -34.65 Mil. |
| Total Income Before Interest Expenses (EBIT) | 48.45 Mil. | -34.96 Mil. | -38.19 Mil. | -39.98 Mil. |
| Total Net Income | 47.85 Mil. | -34.96 Mil. | -38.19 Mil. | -39.98 Mil. |
| Basic EPS, Total | 1.08 | -0.85 | -1.05 | -1.3 |
| Diluted EPS, Total | 1.02 | -0.85 | -1.05 | -1.3 |
| BALANCE STATEMENT | 08/2008 | 08/2007 | 08/2006 | 09/2005 |
|---|---|---|---|---|
| Cash and Equivalents | 420.06 Mil. | 143.43 Mil. | 98.57 Mil. | 49.51 Mil. |
| Total Assets | NA | 343.26 Mil. | 252.29 Mil. | 135.56 Mil. |
| Total Liabilities | NA | 31.7 Mil. | 26.82 Mil. | 23.29 Mil. |
| Total Capitalization | 425.66 Mil. | 340.36 Mil. | 249.78 Mil. | 135.67 Mil. |
| CASH FLOW | 08/2008 | 08/2007 | 08/2006 | 09/2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | -25.85 Mil. | -28.03 Mil. | -23.3 Mil. |
| Net Cash From Investing Activities | NA | -46.74 Mil. | -72.83 Mil. | 19.52 Mil. |
| Net Cash From Financing Activities | NA | 117.45 Mil. | 149.92 Mil. | 2.47 Mil. |
| Net Change in Cash & Cash Equivalents | NA | 44.86 Mil. | 49.06 Mil. | -1.32 Mil. |
